Bluejay Diagnostics shareholders approve 600,000-share increase to 2021 stock plan reserve
PUBT · 06/09 21:27
Share
Listen to the news
- Bluejay Diagnostics held its annual shareholder meeting on June 9, 2026.
- Shareholders backed an amendment allowing a reverse stock split within a 1-for-2 to 1-for-20 range; no split has been implemented.
- Investors adopted an amendment to the 2021 stock plan, lifting the share reserve by 600,000 to 600,061 shares.
- Shareholders ratified Wolf & Company as independent registered public accounting firm for fiscal 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-066896), on June 09, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved